Skip to main content
Log in

Specific effects by the psychotomimetic drugsd-amphetamine and phencyclidine on the performance of an aversely motivated successive visual discrimination in the rat

  • Published:
Amino Acids Aims and scope Submit manuscript

Summary

Rats were trained to perform a conditioned avoidance response to white noise in a conventional two-compartment “shuttle-box”. The partition between the compartments had two openings, however, and the correct passage (leftor right) was signalled by changes in background illumination. In this situation the psychotomimetic compoundsd-amphetamine (4 mg kg−1 IP) and phencyclidine (PCP) (2 mg kg−1 SC) were found to selectively disrupt the visual discrimination. Thed-amphetamine-induced abnormal behavior in this situation has previously been linked to excessive dopamine (DA) receptor stimulation, not controlled by nerve impulse flow and its regulation by important local feed-back mechanisms. Thus, the psychotomimetic effects produced by this compound should not only by due to increased DA receptor activationper se, but also to a disruption of normal patterns of firing and release in dopaminergic neurons. There is evidence to suggest that PCP via an excitatory amino acid (EAA) receptor produces a similar net effect on brain meso-limbic dopaminergic neurotransmission via an increased rate of firing, accompanied by regularization of firing (loss of burst activity). In support for a mediation of PCP-induced effects via EAA receptors, the local application of kynurenic acid into the ventral forebrain (4.7µg, bilaterally) was found also to produce a selective disruption of discriminative performance. It should be noted, however, thatd-amphetamine-induced loss of discriminative behavior, but not that induced by PCP, was antagonized by haloperidol (0.1–0.2 mg kg−1 IP) administration. It is thus possible that at least some effects of PCP in this situation are mediated on the efferent side of the dopaminergic neuron. It is suggested that the abnormal behavior, as evidenced by a loss of discriminative (but not avoidance) behavior, is due to disruption of normal, feed-back regulated, nerve impulse flow.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ahlenius S (1974) Neuropharmacol 13: 729–739

    Google Scholar 

  2. Ahlenius S (1974) Psychopharmacol 39: 199–212

    Google Scholar 

  3. Ahlenius S, Anden N-E, Engel J (1971) Physiol Behav 7: 931–934

    Google Scholar 

  4. Ahlenius S, Anden N-E, Engel J (1973) Brain Res 62: 189–199

    Google Scholar 

  5. Ahlenius S, Archer T (1985) In: Gilles R, Balthazart J (eds) Neurobiology. Springer, Berlin Heidelberg New York Tokyo, pp 329–343

    Google Scholar 

  6. Ahlenius S, Carlsson A, Engel J (1975) J Neural Transm 36: 327–333

    Google Scholar 

  7. Ahlenius S, Engel J (1975) J Neural Transm 36: 43–49

    Google Scholar 

  8. Ahlenius S, Engel J (1976) Psychopharmacol 49: 63–68

    Google Scholar 

  9. Anden N-E, Carlsson A, Häggendal J (1969) Annu Rev Pharmacol Toxicol 9: 119–134

    Google Scholar 

  10. Andreasen NC, Olsen S (1982) Arch Gen Psychiat 39: 789–794

    Google Scholar 

  11. Balster RL (1987) In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 1573–1579

    Google Scholar 

  12. Bunney BS, Walters JR, Roth RH, Aghajanian GK (1973) J Pharmacol Exp Ther 185: 560–571

    Google Scholar 

  13. Carlsson A (1965) In: Eichler O, Farah A (eds) Handbook of experimental pharmacology. Springer, Berlin Heidelberg New York, pp 529–592

    Google Scholar 

  14. Carlsson A (1988) Neuropsychopharmacol 1: 179–186

    Google Scholar 

  15. Carlsson M, Carlsson A (1990) TINS 13: 272–276

    Google Scholar 

  16. Corrodi H, Fuxe K (1967) Life Sci 6: 1345–1350

    Google Scholar 

  17. Corrodi H, Fuxe K, Hökfelt T (1966) Life Sci 5: 605–611

    Google Scholar 

  18. Cotman CW, Monaghan DT (1987) In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 197–210

    Google Scholar 

  19. Ericson E, Ahlenius S (1990) Psychopharmacol 102: 171–174

    Google Scholar 

  20. Ericson E, Svensson TH, Ahlenius S (1990) Pharmacol Biochem Behav 37: 843–845

    Google Scholar 

  21. Fischman MW (1987) In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 1543 -1553

    Google Scholar 

  22. Gonon FG (1988) Neurosci 24: 19–28

    Google Scholar 

  23. Gonon FG, Buda MJ (1985) Neurosci 14: 765–774

    Google Scholar 

  24. Grenhoff J, Tung C-S, Svensson TH (1988) Acta Physiol Scand 134: 567–568

    Google Scholar 

  25. Grenhoff J, Ugedo L, Svensson TH (1988) Acta Physiol Scand 134: 127–132

    Google Scholar 

  26. Johnson KM, Jones SM (1990) Annu Rev Pharmacol Toxicol 30: 707–750

    Google Scholar 

  27. Kehr W (1976) Drug Res 26: 1086–1088

    Google Scholar 

  28. Li CC (1964) Introduction to experimental statistics. McGraw-Hill, New York

    Google Scholar 

  29. Löffelholz K, Muscholl E (1970) Naunyn-Schmiedeberg's Arch Pharmacol 266: 393–394

    Google Scholar 

  30. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1959) Arch Neurol Psychiatry 81: 363–369

    Google Scholar 

  31. Luby ED, Gottlieb JS, Cohen BD, Rosenbaum G, Domino EF (1962) Am J Psychiatry 119: 61–67

    Google Scholar 

  32. Malmfors T (1965) Acta Physiol Scand 64S248: 1–93

    Google Scholar 

  33. Moore KE, Dominic JA (1971) Federation Proc 30: 859–870

    Google Scholar 

  34. Obianwu HO (1969) Acta Physiol Scand 75: 102–110

    Google Scholar 

  35. Obianwu HO (1969) Acta Physiol Scand 75: 92–101

    Google Scholar 

  36. Olney JW (1990) Annu Rev Pharmacol Toxicol 30: 47–71

    Google Scholar 

  37. Pawlowski L, Mathe JM, Svensson TH (1990) Acta Physiol Scand 139: 529–530

    Google Scholar 

  38. Randrup A, Munkvad I (1969) Ann NY Acad Sci 159: 928–938

    Google Scholar 

  39. Sass H (1989) Br J Psychiat 155 [Suppl]7: 26–30

    Google Scholar 

  40. Seiden LS, Dykstra LA (1977) Van Nostrand Reinhold Co, New York

  41. Siegel S (1956) Nonparametric statistics for the behavioral sciences. McGraw-Hill, New York

    Google Scholar 

  42. Smith AD, Winkler H (1972) In: Blaschko H, Muscholl E (eds) Handbook of experimental pharmacology. Springer, Berlin Heidelberg New York, pp 538–617

    Google Scholar 

  43. Sutherland NS, Mackintosh NJ (1971) Academic Press, New York

  44. van OrdenIII LS, Bensch KG, Giarman NJ (1967) J Pharmacol Exp Ther 155: 428–439

    Google Scholar 

  45. von Voigtlander PF, Moore KE (1973) J Pharmacol Exp Ther 184: 542–552

    Google Scholar 

  46. Zetterström T, Sharp T, Ungerstedt U (1986) Eur J Pharmacol 132: 1–9

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahlenius, S., Ericson, E. & Svensson, T.H. Specific effects by the psychotomimetic drugsd-amphetamine and phencyclidine on the performance of an aversely motivated successive visual discrimination in the rat. Amino Acids 3, 69–79 (1992). https://doi.org/10.1007/BF00806009

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00806009

Keywords

Navigation